S Temizkan1, O Deyneli1, M Yasar1, M Arpa2, M Gunes1, D Yazici1, O Sirikci2, G Haklar2, N Imeryuz3, D G Yavuz1. 1. Department of Endocrinology and Metabolic Diseases, Marmara University Faculty of Medicine, Istanbul, Turkey. 2. Department of Biochemistry, Marmara University Faculty of Medicine, Istanbul, Turkey. 3. Department of Gastroenterology, Marmara University Faculty of Medicine, Istanbul, Turkey.
Abstract
BACKGROUND/ OBJECTIVE: Artificial sweeteners were thought to be metabolically inactive, but after demonstrating that the gustatory mechanism was also localized in the small intestine, suspicions about the metabolic effects of artificial sweeteners have emerged. The objective of this study was to determine the effect of artificial sweeteners (aspartame and sucralose) on blood glucose, insulin, c-peptide and glucagon-like peptide-1 (GLP-1) levels. SUBJECTS/ METHODS: Eight newly diagnosed drug-naive type 2 diabetic patients (mean age 51.5±9.2 years; F/M: 4/4) and eight healthy subjects (mean age 45.0±4.1 years; F/M: 4/4) underwent 75 g oral glucose tolerance test (OGTT). During OGTT, glucose, insulin, c-peptide and GLP-1 were measured at 15- min intervals for 120 min. The OGTTs were performed at three settings on different days, where subjects were given 72 mg of aspartame and 24 mg of sucralose in 200 ml of water or 200 ml of water alone15 min before OGTT in a single-blinded randomized order. RESULTS: In healthy subjects, the total area under the curve (AUC) of glucose was statistically significantly lower in the sucralose setting than in the water setting (P=0.002). There was no difference between the aspartame setting and the water setting (P=0.53). Total AUC of insulin and c-peptide was similar in aspartame, sucralose and water settings. Total AUC of GLP-1 was significantly higher in the sucralose setting than in the water setting (P=0.04). Total AUC values of glucose, insulin, c-peptide and GLP-1 were not statistically different in three settings in type 2 diabetic patients. CONCLUSIONS: Sucralose enhances GLP-1 release and lowers blood glucose in the presence of carbohydrate in healthy subjects but not in newly diagnosed type 2 diabetic patients.
RCT Entities:
BACKGROUND/ OBJECTIVE: Artificial sweeteners were thought to be metabolically inactive, but after demonstrating that the gustatory mechanism was also localized in the small intestine, suspicions about the metabolic effects of artificial sweeteners have emerged. The objective of this study was to determine the effect of artificial sweeteners (aspartame and sucralose) on blood glucose, insulin, c-peptide and glucagon-like peptide-1 (GLP-1) levels. SUBJECTS/ METHODS: Eight newly diagnosed drug-naive type 2 diabeticpatients (mean age 51.5±9.2 years; F/M: 4/4) and eight healthy subjects (mean age 45.0±4.1 years; F/M: 4/4) underwent 75 g oral glucose tolerance test (OGTT). During OGTT, glucose, insulin, c-peptide and GLP-1 were measured at 15- min intervals for 120 min. The OGTTs were performed at three settings on different days, where subjects were given 72 mg of aspartame and 24 mg of sucralose in 200 ml of water or 200 ml of water alone 15 min before OGTT in a single-blinded randomized order. RESULTS: In healthy subjects, the total area under the curve (AUC) of glucose was statistically significantly lower in the sucralose setting than in the water setting (P=0.002). There was no difference between the aspartame setting and the water setting (P=0.53). Total AUC of insulin and c-peptide was similar in aspartame, sucralose and water settings. Total AUC of GLP-1 was significantly higher in the sucralose setting than in the water setting (P=0.04). Total AUC values of glucose, insulin, c-peptide and GLP-1 were not statistically different in three settings in type 2 diabeticpatients. CONCLUSIONS:Sucralose enhances GLP-1 release and lowers blood glucose in the presence of carbohydrate in healthy subjects but not in newly diagnosed type 2 diabeticpatients.
Authors: K C Maki; L L Curry; M S Reeves; P D Toth; J M McKenney; M V Farmer; S L Schwartz; B C Lubin; A C Boileau; M R Dicklin; M C Carakostas; S M Tarka Journal: Food Chem Toxicol Date: 2008-05-16 Impact factor: 6.023
Authors: Kirsten Vollmer; Jens J Holst; Birgit Baller; Mark Ellrichmann; Michael A Nauck; Wolfgang E Schmidt; Juris J Meier Journal: Diabetes Date: 2007-12-05 Impact factor: 9.461
Authors: Hyeung-Jin Jang; Zaza Kokrashvili; Michael J Theodorakis; Olga D Carlson; Byung-Joon Kim; Jie Zhou; Hyeon Ho Kim; Xiangru Xu; Sic L Chan; Magdalena Juhaszova; Michel Bernier; Bedrich Mosinger; Robert F Margolskee; Josephine M Egan Journal: Proc Natl Acad Sci U S A Date: 2007-08-27 Impact factor: 11.205
Authors: Tongzhi Wu; Michelle J Bound; Scott D Standfield; Max Bellon; Richard L Young; Karen L Jones; Michael Horowitz; Christopher K Rayner Journal: Diabetes Care Date: 2013-12 Impact factor: 19.112
Authors: Alicia L Carreiro; Jaapna Dhillon; Susannah Gordon; Kelly A Higgins; Ashley G Jacobs; Breanna M McArthur; Benjamin W Redan; Rebecca L Rivera; Leigh R Schmidt; Richard D Mattes Journal: Annu Rev Nutr Date: 2016-07-17 Impact factor: 11.848
Authors: Jelle R Dalenberg; Barkha P Patel; Raphael Denis; Maria G Veldhuizen; Yuko Nakamura; Petra C Vinke; Serge Luquet; Dana M Small Journal: Cell Metab Date: 2020-03-03 Impact factor: 27.287